These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9607865)

  • 1. Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada.
    Kertesz DA; Coulthart MB; Ryan JA; Johnson WM; Ashton FE
    J Infect Dis; 1998 Jun; 177(6):1754-7. PubMed ID: 9607865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease.
    Raymond NJ; Reeves M; Ajello G; Baughman W; Gheesling LL; Carlone GM; Wenger JD; Stephens DS
    J Infect Dis; 1997 Nov; 176(5):1277-84. PubMed ID: 9359729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLEE and PFGE characterization of Neisseria meningitidis serogroup C and B isolated in the Slovak Republic in 1998.
    Karelová E; Krízová P; Musílek M
    Cent Eur J Public Health; 2002 Jun; 10(1-2):60-5. PubMed ID: 12096686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic fingerprinting of Neisseria meningitidis associated with group C meningococcal disease in Canada.
    Strathdee CA; Tyler SD; Ryan JA; Johnson WM; Ashton FE
    J Clin Microbiol; 1993 Sep; 31(9):2506-8. PubMed ID: 8408577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal disease in South Africa, 1999-2002.
    Coulson GB; von Gottberg A; du Plessis M; Smith AM; de Gouveia L; Klugman KP;
    Emerg Infect Dis; 2007 Feb; 13(2):273-81. PubMed ID: 17479891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of Canadian isolates of C:2a:P1.2,5 and B:2a:P1.2,5 Neisseria meningitidis strains belonging to the hypervirulent clone of ET-15.
    Tyler S; Tsang R
    Can J Microbiol; 2004 Jun; 50(6):433-43. PubMed ID: 15284889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002-2006.
    Simões MJ; Cunha M; Almeida F; Furtado C; Brum L
    Epidemiol Infect; 2009 Feb; 137(2):161-5. PubMed ID: 18667108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013-2015.
    Carville KS; Stevens K; Sohail A; Franklin LJ; Bond KA; Brahmi A; Romanes F; Ong KS
    Emerg Infect Dis; 2016 Oct; 22(10):1785-7. PubMed ID: 27648521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disease burden of invasive meningococcal serogroup B disease in Canada.
    Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
    Pediatr Infect Dis J; 2013 Jan; 32(1):e20-5. PubMed ID: 22926207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C.
    Berrón S; De La Fuente L; Martín E; Vázquez JA
    Eur J Clin Microbiol Infect Dis; 1998 Feb; 17(2):85-9. PubMed ID: 9629971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.
    Erickson L; De Wals P
    Clin Infect Dis; 1998 May; 26(5):1159-64. PubMed ID: 9597245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
    Diermayer M; Hedberg K; Hoesly F; Fischer M; Perkins B; Reeves M; Fleming D
    JAMA; 1999 Apr; 281(16):1493-7. PubMed ID: 10227318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive meningococcal disease associated with a very high case fatality rate in the North-West of Poland.
    Skoczyńska A; Kadłubowski M; Knap J; Szulc M; Janusz-Jurczyk M; Hryniewicz W
    FEMS Immunol Med Microbiol; 2006 Mar; 46(2):230-5. PubMed ID: 16487304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serogroup Y meningococcal disease in Chicago, 1991-1997.
    Racoosin JA; Whitney CG; Conover CS; Diaz PS
    JAMA; 1998 Dec 23-30; 280(24):2094-8. PubMed ID: 9875877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis.
    Whalen CM; Hockin JC; Ryan A; Ashton F
    JAMA; 1995 Feb; 273(5):390-4. PubMed ID: 7823384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neisseria meningitidis carriage during an outbreak of serogroup C disease.
    Patrick DM; Champagne S; Goh SH; Arsenault G; Thomas E; Shaw C; Rahim T; Taha F; Bigham M; Dubenko V; Skowronski D; Brunham RC
    Clin Infect Dis; 2003 Nov; 37(9):1183-8. PubMed ID: 14557962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report of the Australian Meningococcal Surveillance Programme, 2011.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2012 Sep; 36(3):E251-62. PubMed ID: 23186236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.
    Vickers DM; Anonychuk AM; De Wals P; Demarteau N; Bauch CT
    Vaccine; 2015 Jan; 33(1):268-75. PubMed ID: 24103896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent emergence of serogroup C meningococcal disease in Greece.
    Kremastinou J; Tzanakaki G; Kansouzidou A; Pagalis A; Danielides V; Kouppari G; Lada E; Kriz P; Musilek M; Weir DM; Blackwell CC
    FEMS Immunol Med Microbiol; 1999 Jan; 23(1):49-55. PubMed ID: 10030547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.